Position in TNYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,079,477
+$229,809 QoQ
Shares Held
1,559,939
+30.7% QoQ
Ownership
0.719%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 103 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,556,641,344 across 524 Biotechnology names. TNYA ranks #309 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in TNYA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,079,477 | 1,559,939 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $849,668 | 1,193,355 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,904,366 | 1,175,535 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $751,892 | 1,230,594 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $783,852 | 1,375,181 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,814,293 | 1,268,737 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,501,580 | 1,296,156 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,810,482 | 1,229,188 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,439,440 | 1,040,046 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,009,192 | 928,763 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,226,693 | 873,213 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,810,887 | 819,572 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,253,751 | 790,790 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $956,245 | 475,744 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,304,733 | 449,908 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,143,008 | 380,641 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,337,596 | 368,217 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,342,184 | 229,139 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,459,635 | 215,963 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||